# Integre Pro, Model L2RY

> Active: European Union and United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/integre-pro-model-l2ry-hqf>
- Manufacturer: [Ellex Medical Pty Ltd](https://devicerts.com/manufacturers/ellex-medical-pty-ltd) (Australia)
- Name in the registry: INTEGRE PRO, MODEL L2RY
- Device class: Class II (US FDA)
- FDA product code: HQF

## Overview

*AI-generated summary, 2026-09-18. Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data is the record.*

The Integre Pro, Model L2RY, is a Laser, Ophthalmic device designed for retinal photocoagulation and treatment of ocular conditions. It delivers controlled laser energy to the retina, aiding in the management of diabetic retinopathy, retinal tears, and other retinal pathologies by promoting tissue healing or sealing abnormal blood vessels.

This device is supplied as a reusable medical instrument, intended for use in clinical ophthalmology settings. It requires proper sterilisation and maintenance as per manufacturer guidelines, with no specific MRI safety restrictions noted. The device is authorised under FDA 510K and MDR compliance, adhering to regulatory standards for ophthalmic laser systems. Storage and handling must follow sterile instrument protocols to ensure safety and functionality.

## Registrations and authorizations

- **510(k)** · FDA 510(k) · United States · K081565 · decision 2008-07-02 · decision SESE · status: Active
- **EUDAMED** · CE/MDR · European Union · status: Active

## Recalls

- Z-1971-2023 · Class II · ongoing · initiated 2023-03-16: When using a Laser-Indirect-Ophthalmoscope (LIO) as the delivery device, a scattered laser beam inside the laser cavity system may unintentionally exit through the Slit Lamp output port (SDS) and get emitted from the Objective Lens when the laser is fired.

## Identifiers

- 510(k) Number: K081565 [FDA 510(k)]
- FDA product code: HQF [FDA 510(k)]

## Classification

- Device class: Class II [FDA 510(k)]
- Regulation: 21 CFR Part 886.4390 [FDA 510(k)]
- Advisory committee: Ophthalmic [FDA 510(k)]
- FDA decision: SESE [FDA 510(k)]

## Source and citation

- Cite as: Integre Pro, Model L2RY, Ellex Medical Pty Ltd. deviCERTS medical device catalogue. https://devicerts.com/devices/integre-pro-model-l2ry-hqf (data as of 2026-11-17).
- Data sources: [FDA 510(k)](https://open.fda.gov/apis/device/510k/), [EUDAMED](https://ec.europa.eu/tools/eudamed), [FDA recalls](https://open.fda.gov/apis/device/recall/)
- Registry records last synced: 2026-11-13
- Statuses computed as of: 2026-11-17
- JSON: <https://devicerts.com/devices/integre-pro-model-l2ry-hqf.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/integre-pro-model-l2ry-hqf
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
